Company news
Willfar Information Technology Co., Ltd. news in 2026
Willfar Information Technology Co., Ltd.'s news releases, calls and decks from 2026, newest first.
(688100)"Willfar Information Technology Co., Ltd."Announcement on Voluntary Disclosure of Awarded Contracts in October 2026
November 3, 2026
(688100)"Willfar Information Technology Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
November 2, 2026
(688100)"Willfar Information Technology Co., Ltd."Report for Q3 2026
October 29, 2026
(688100)"Willfar Information Technology Co., Ltd."Announcement on Voluntary Disclosure of Awarded Contracts in September 2026
October 8, 2026
(688100)"Willfar Information Technology Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
October 8, 2026
Announcement on Voluntary Disclosure of Bid-Winning Contracts in August 2026
September 1, 2026
Announcement on Repurchase of Shares through Call Auction Reaching 2% and Progress of Share Repurchase
August 31, 2026
Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance Briefing
August 25, 2026
Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
August 20, 2026
Announcement on the Initial Repurchase of Shares through Call Auction
August 19, 2026
Announcement on Resolutions of the 3rd Meeting of the 4th Board of Directors
August 17, 2026
Semi-annual Report for 2026
August 16, 2026
Announcement on Implementation Result of Share Repurchase
July 20, 2026
Announcement on Repurchase of 1% Shares through Call Auction and Progress of Share Repurchase
July 13, 2026
Announcement on Voluntary Disclosure of Contract Awards in June 2026
July 1, 2026
Announcement on Initially Repurchasing the Company's Shares through Call Auction
June 26, 2026
Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Herui's budesonide enteric capsules, further enhancing patient access to the medication
June 24, 2026
Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Not Subject to Sales Restrictions Concerning Share Repurchase
June 22, 2026
Announcement on Resolutions of the 1st Meeting of the 4th Board of Directors
June 18, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
June 17, 2026
Notice on Convening the 2nd Extraordinary General Meeting in 2026
June 2, 2026
Announcement on Voluntary Disclosure of Bid-winning Contracts in May 2026
June 1, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
May 15, 2026
Announcement on Voluntary Disclosure of Bid-winning Contracts in April 2026
May 6, 2026
Announcement on Amending the "Articles of Association"
April 28, 2026
Indicative Announcement on Expiration of the 2nd Lock-up Period of Employee Stock Ownership Plan Phase I
April 7, 2026
Announcement on Implementation of Dividend Distribution for 2025
April 6, 2026
Announcement on Voluntary Disclosure of Bid-winning Contracts in March 2026
April 1, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
March 20, 2026
Notice on Convening the Annual General Meeting in 2025
February 27, 2026
Announcement on Holding Investor Reception Day
January 12, 2026
Announcement on Voluntary Disclosure of Bid-winning Contracts in December 2025
January 6, 2026